Position in ELAN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$5,339,385
-$898,830 QoQ
Shares Held
216,960
-16.8% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#125
of 515 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $63,112,823 across 13 Drug Manufacturers - Specialty & Generic names. ELAN ranks #3 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
765,543 | $40,114,453 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
443,647 | $7,679,529 | |
| 3 | ELAN |
Elanco Animal Health Inc
This page
|
216,960 | $5,339,385 | |
| 4 | EBS |
Emergent BioSolutions Inc.
|
329,060 | $2,757,522 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
227,579 | $1,802,425 | |
| 6 | ZTS |
Zoetis Inc.
|
22,499 | $1,616,778 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
2,880 | $1,560,470 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
18,763 | $635,690 |
All Filings in ELAN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,339,385 | 216,960 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $6,238,215 | 260,686 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,941,597 | 262,554 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $594,452 | 29,516 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $422,102 | 29,559 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $358,176 | 34,112 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,802,234 | 148,822 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,334,141 | 1,179,996 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,170,776 | 219,735 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $6,988,531 | 429,271 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $5,991,886 | 402,140 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $4,627,789 | 411,725 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $442,479 | 43,984 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $640,572 | 68,146 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $804,198 | 65,810 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $523,540 | 42,187 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $475,674 | 24,232 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $632,212 | 24,232 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $520,375 | 18,336 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $703,429 | 22,058 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $765,192 | 22,058 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $698,259 | 23,710 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $618,920 | 20,180 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $349,711 | 12,521 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $15,808 | 737 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||